Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD

Marta Wiszniewska (Lodz, Poland), Marta Wiszniewska, Aneta Kleniewska, Ewa Nowakowska-Swirta, Diana Tymoszuk, Agnieszka Lipinska-Ojrzanowska, Jolanta Walusiak-Skorupa

Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marta Wiszniewska (Lodz, Poland), Marta Wiszniewska, Aneta Kleniewska, Ewa Nowakowska-Swirta, Diana Tymoszuk, Agnieszka Lipinska-Ojrzanowska, Jolanta Walusiak-Skorupa. Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD. Eur Respir J 2016; 48: Suppl. 60, 4273

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

The correlation between expression of selected inflammatory mediators in induced sputum and respiratory tests in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016

Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

LATE-BREAKING ABSTRACT: Cytokines and MMP 9 level in serum and induced sputum of patients with suspicion of occupational COPD
Source: Annual Congress 2012 - Respiratory diseases at at work: epidemiology, inflammation and challenge studies
Year: 2012


Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014

Plasma levels of TIPM-2 in patients with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Serum periostin but not airway POSTN expression is reduced in smokers with asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013

IL32 expression in induced sputum of COPD subjects
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015

Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Presence of progranulin in airway inflammation associated with COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Elevated sputum BPIFB1 levels correlate with progression of chronic obstructive pulmonary disease
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015


The effect of smoking on the activity of inflammatory markers in patients with COPD
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013


The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013